Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bar-Or

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosisT Vollmer, H Panitch, A Bar-Or, et al.
Neurology|April 30, 2010
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosisJ M Burton, S Kimball, R Vieth, et al.
Journal of Neuroimmunology|July 20, 2010
Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2Y Zhang, F Jalili, N Ouamara, et al.
Neurology|October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisM Mehling, V Brinkmann, J Antel, et al.
Neurology|December 21, 2007
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disordersB Banwell, S Tenembaum, V A Lennon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2012
Impact of sleep disorder treatment on fatigue in multiple sclerosisI Côté, D A Trojan, M Kaminska, et al.
Neurology|February 4, 2011
Mitochondrial DNA haplogroups and mutations in children with acquired central demyelinationS Venkateswaran, K Zheng, M Sacchetti, et al.
Neurology|March 29, 2006
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapsesP W O'Connor, D Li, M S Freedman, et al.
Neurology|October 7, 2011
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MSM S Freedman, A Bar-Or, J Oger, et al.
Neurology|February 4, 2012
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assaysP J Waters, A McKeon, M I Leite, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosisT Vollmer, H Panitch, A Bar-Or, et al.
Neurology|April 30, 2010
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosisJ M Burton, S Kimball, R Vieth, et al.
Journal of Neuroimmunology|July 20, 2010
Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2Y Zhang, F Jalili, N Ouamara, et al.
Neurology|October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisM Mehling, V Brinkmann, J Antel, et al.
Neurology|December 21, 2007
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disordersB Banwell, S Tenembaum, V A Lennon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2012
Impact of sleep disorder treatment on fatigue in multiple sclerosisI Côté, D A Trojan, M Kaminska, et al.
Neurology|February 4, 2011
Mitochondrial DNA haplogroups and mutations in children with acquired central demyelinationS Venkateswaran, K Zheng, M Sacchetti, et al.
Neurology|March 29, 2006
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapsesP W O'Connor, D Li, M S Freedman, et al.
Neurology|October 7, 2011
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MSM S Freedman, A Bar-Or, J Oger, et al.
Neurology|February 4, 2012
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assaysP J Waters, A McKeon, M I Leite, et al.
Pageof 4